Comorbidity and Multimorbidity of Asthma and Allergy and Intolerance to Chemicals and Certain Buildings

J Occup Environ Med. 2017 Jan;59(1):80-84. doi: 10.1097/JOM.0000000000000930.

Abstract

Objectives: We tested the hypothesis of high comorbidity between asthma/allergy and chemical intolerance (CI) and between asthma/allergy and building intolerance (BI), and high multimorbidity between asthma/allergy, CI, and BI.

Methods: Population-based questionnaire data were used from 530 participants with asthma/allergy (allergic asthma, nonallergic asthma, allergic rhinitis, and/or atopic dermatitis), 414 with self-reported and 112 with physician-diagnosed CI, and 165 with self-reported and 47 with physician-diagnosed BI. Separate reference groups were formed for each of the five case groups.

Results: Adjusted odds ratios varied from 4.6 to 13.1 for comorbidity, and from 6.6 to 46.4 for multimorbidity.

Conclusion: The large comorbidity and multimorbidity between asthma/allergy, CI, and BI evokes the question as to whether there are similarities in underlying mechanisms between these conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Asthma / epidemiology*
  • Comorbidity
  • Dermatitis, Atopic / epidemiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Chemical Sensitivity / diagnosis
  • Multiple Chemical Sensitivity / epidemiology*
  • Rhinitis, Allergic / epidemiology*
  • Sick Building Syndrome / diagnosis
  • Sick Building Syndrome / epidemiology*
  • Surveys and Questionnaires